Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Handling missing items in the Exacerbations of Chronic Pulmonary Disease Tool

Andrew W. Hitchings, Emma H. Baker, Paul W. Jones
European Respiratory Journal 2016 48: 564-566; DOI: 10.1183/13993003.00269-2016
Andrew W. Hitchings
Institute for Infection and Immunity, St George's, University of London, London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew W. Hitchings
Emma H. Baker
Institute for Infection and Immunity, St George's, University of London, London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul W. Jones
Institute for Infection and Immunity, St George's, University of London, London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pjones@sgul.ac.uk
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Within certain limits, missing items in the EXACT instrument can be imputed from the remaining answered items http://ow.ly/4mJQzP

To the Editor:

The Exacerbations of Chronic Pulmonary Disease Tool (EXACT) is a 14-item, self-administered daily symptom diary designed to identify and characterise exacerbations of chronic obstructive pulmonary disease (COPD). It provides a reliable, valid and standardised measure of exacerbation symptoms, and is sensitive to changes during recovery [1]. Scores are expressed on a 100-point scale, with higher values indicating worse symptoms or health state. In addition, the EXACT-derived E-RS (EXACT Respiratory Symptoms) provides valid daily COPD symptom scores [2, 3]. Electronic administration is recommended and has several advantages, notably in preventing item omission [4]. However, the expense of electronic solutions may prove prohibitive, particularly in noncommercial studies, when a pen-and-paper version may be used instead. In this context, it is important to have a method to deal with missing items. This is yet to be established.

In psychometrically validated instruments with high internal consistency, such as the EXACT (Cronbach-α ≥0.9 [1, 5]), missing items may be imputed from the remaining answered items [6]. Used appropriately, this is preferable to list-wise deletion of incomplete records, which reduces power and risks introducing bias if data are missed not at random, and to substituting values from neighbouring records (“last observation carried forward” or “next value carried backward”), as this assumes symptoms are in steady state, which is unlikely during an exacerbation [6]. However, imputing items increases random error and, if items are missed systematically, may introduce bias. These factors limit the number and combination of items that can be imputed without excessively compromising reliability and accuracy. We sought to define the parameters under which this may be done by simulating item imputation on complete EXACT records from a recent study.

The study was an investigator-led, multicentre, randomised, double-blind, placebo-controlled trial (www.clinicaltrials.gov identifier number NCT01247870 and www.isrctn.com identifier number ISRCTN66148745). Its methods and results are detailed elsewhere [7]. Briefly, the trial tested metformin in 52 patients admitted to hospital for COPD exacerbations, primarily to establish its antihyperglycaemic effect. Secondary end-points included symptomatic recovery, as determined by the EXACT. Eligible patients were aged ≥35 years, had established COPD and had been admitted for an exacerbation with an expected inpatient stay ≥48 h. Participants completed the EXACT on paper every evening for 1 month, including in hospital. Guidance was provided by investigators in person during the inpatient phase and telephone support was available following discharge.

The effect of imputing items was simulated on EXACT diary records from the first 17 participants, representing all participants enrolled by the time of this analysis. This dataset comprised 361 EXACT diary records, of which 302 (84%) were complete. In the first simulation, one randomly selected item was deleted from each complete record and an imputed score substituted in its place. Imputed scores were calculated as the mean raw score from the remaining items, rounded to the nearest integer and capped at the maximum available for the item being imputed. The total imputed and actual raw scores were transformed to a 100-point linear scale for analysis and interpretation [4]. The degree to which systematic error (bias) was introduced by imputation was quantified by the mean difference between imputed and actual scores (imputed−actual). Random error was quantified by the standard deviation of the difference and 95% limits of agreement were calculated [8]. To stabilise the estimates, they were averaged from 500 iterations of the item-imputation simulations. The same procedure was adopted to evaluate the effects of imputing 2–6 randomly selected items.

To identify items susceptible to systematic omission due to changing symptoms or setting of care, omission rates were compared between the inpatient and outpatient phases of the study. Those items with differential omission rates were subjected to further analysis using complete EXACT records from all 52 trial participants, systematically imputing these items on 12 representative days (days 2–10, 15, 20 and 28, where day 1 was defined as the day of admission). Mean difference, standard deviation and 95% limits of agreement were calculated for all possible item-omission combinations for these three items.

Overall, the mean±sd difference between imputed and actual scores ranged from −0.06±1.12 to +0.26±4.42 points, depending on the number of items imputed. These differences and their 95% limits of agreement are illustrated in figure 1. Items that were omitted significantly more frequently in the inpatient phase were item 9 (breathlessness with personal care; omitted on 5% of inpatient days versus 1% of outpatient days), item 10 (breathlessness with indoor activities; 28%  versus 10%, respectively) and item 11 (breathlessness without outdoor activities; 31% versus 15%, respectively) (p<0.001 in each case). For these items, the overall mean±sd difference (95% limits of agreement) was −0.6±0.8 (−2.2– +1.1) points when any one item was imputed, −1.2±1.6 (−4.2– +1.9) when any two items were imputed and −2.0±0.3 (−6.6– +2.8) when all three were imputed. This appeared stable over the 12 days on which this was analysed.

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Difference between imputed and actual Exacerbations of Chronic Pulmonary Disease Tool (EXACT) scores, according to the number of items imputed. EXACT scores are expressed on a 100-point scale, with higher scores indicating worse symptoms or health state. Black circles denote the mean difference between actual and imputed scores, error bars denote the standard deviation of the difference and dashed lines indicate 95% limits of agreement. These estimates were generated from 500 iterations of random item-imputation simulations. Illustrative data points from one such iteration are denoted by grey spots. #: imputed−actual.

Our results suggest that, in general, imputation introduces negligible systematic bias in the total EXACT score, but random error increases progressively with the number of items imputed. The average intrapatient day-to-day variability in EXACT scores is ∼5 points [1] and we considered this a reasonable benchmark against which to set the tolerance margin for imputation. In general, the 95% limits of agreement are within this margin provided that no more than three items are imputed. Items 9–11 represent a special case, because their omission had a systematic component. Imputing these items generated bias towards underestimating the actual score. To keep the 95% limits of agreement within the 5-point tolerance margin, no more than two of these items should be imputed. In doing this, a mean bias of −1.2 points is generated. This is relatively small in comparison to the effect of an exacerbation (generally ≥10 points [5, 9]) but it should be borne in mind during data interpretation. The high omission rates for items 9–11 among hospital inpatients may raise questions over their validity in this setting. However, while the method we have proposed can compensate for partial missing data, prospectively removing these items for inpatients would require a new validation process.

A limitation of these simulations is that, by necessity, they were performed on complete diary records. One cannot know whether imputation has the same effects where the participants have themselves elected to omit items. The pattern of omission suggests that this might occur where participants consider the questions inapplicable to their present condition. For example, the patients may judge that quantifying breathlessness outside the home may be inapplicable whilst they are in hospital. Compelled to answer, these patients may have responded differently to those who answered the question from the outset. That said, we stressed to participants in the trial the importance of answering all items on every occasion. Consequently, the dataset probably includes reasonable representation from participants who recognised the same incongruence but answered the question anyway.

In conclusion, we recommend that missing EXACT items may be imputed from the remaining answered items, provided no more than three items are imputed in total, including no more than two of items 9–11. The imputed score is calculated from the mean of the remaining item scores, rounded to the nearest integer and capped at the maximum score available for that item.

Acknowledgements

We thank Nancy Kline Leidy and Elizabeth Bacci (Evidera, Bethesda, MD, USA) for their helpful comments on the first draft of this manuscript. We thank the NIHR Clinical Research Network Portfolio, Comprehensive Local Research Networks and the participating centres for their support in conducting the clinical trial from which these data were acquired.

Footnotes

  • Clinical trial: This study is registered at www.clinicaltrials.gov with identifier number NCT01247870 and www.isrctn.com with identifier number ISRCTN66148745

  • Support statement: This clinical trial was funded by the British Lung Foundation (grant number COPD10/7) and the Medical Research Council (MR/J010235/1). The funders had no involvement in the collection, analysis or interpretation of data; the writing of the report; or the decision to submit the paper for publication. Funding information for this article has been deposited with FundRef.

  • Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com

  • Received February 4, 2016.
  • Accepted April 6, 2016.
  • Copyright ©ERS 2016

References

  1. ↵
    1. Leidy NK,
    2. Wilcox TK,
    3. Jones PW, et al.
    Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary. Am J Respir Crit Care Med 2011; 183: 323–329.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Leidy NK,
    2. Murray LT,
    3. Monz BU, et al.
    Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials. Respir Res 2014; 15: 124.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Leidy NK,
    2. Sexton CC,
    3. Jones PW, et al.
    Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary. Thorax 2014; 69: 443–449.
    OpenUrlPubMed
  4. ↵
    EXACT-PRO Initiative. The Exacerbations of Chronic Pulmonary Disease Tool (EXACT) Patient-Reported Outcome (PRO) user manual (version 6.0). Bethesda, Evidera, 2013.
  5. ↵
    1. Leidy NK,
    2. Murray LT,
    3. Jones P, et al.
    Performance of the EXAcerbations of Chronic pulmonary disease Tool patient-reported outcome measure in three clinical trials of chronic obstructive pulmonary disease. Ann Am Thorac Soc 2014; 11: 316–325.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Bell ML,
    2. Fairclough DL
    . Practical and statistical issues in missing data for longitudinal patient-reported outcomes. Stat Methods Med Res 2014; 23: 440–459.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Hitchings AW,
    2. Lai D,
    3. Jones PW
    , et al. Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial. Thorax 2016; 71: 587–593.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Bland JM,
    2. Altman DG
    . Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307–310.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Mackay AJ,
    2. Donaldson GC,
    3. Patel AR, et al.
    Detection and severity grading of COPD exacerbations using the exacerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT). Eur Respir J 2014; 43: 735–744.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
View this article with LENS
Vol 48 Issue 2 Table of Contents
European Respiratory Journal: 48 (2)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Handling missing items in the Exacerbations of Chronic Pulmonary Disease Tool
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Handling missing items in the Exacerbations of Chronic Pulmonary Disease Tool
Andrew W. Hitchings, Emma H. Baker, Paul W. Jones
European Respiratory Journal Aug 2016, 48 (2) 564-566; DOI: 10.1183/13993003.00269-2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Handling missing items in the Exacerbations of Chronic Pulmonary Disease Tool
Andrew W. Hitchings, Emma H. Baker, Paul W. Jones
European Respiratory Journal Aug 2016, 48 (2) 564-566; DOI: 10.1183/13993003.00269-2016
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Fixed breathing protocols in multiple-breath washout testing in children
  • Fixed breathing protocols in multiple-breath washout testing in children
  • Bedaquiline and delamanid for the treatment of MDR-TB
Show more Agora

Research letters

  • Bedaquiline and delamanid for the treatment of MDR-TB
  • Clump material within drainage chest tubes contains diagnostic information
  • Leukocyte telomere length and mycophenolate therapy in CHP
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society